Earnings

Bayer's pharmaceutical division has encountered a significant clinical development hurdle as its promising heart failure drug candidate, Vericiguat, failed to...

In the intensifying battle for dominance in the multi-billion dollar weight-loss drug market, Novo Nordisk has delivered a powerful counterpunch....

The memory chip sector is experiencing a remarkable upswing, and Micron Technology is positioned directly at its center. The company...

Super Micro Computer's stock has entered a pronounced downward trajectory, with shares declining over 26% during August 2025 alone. This...

Pharmaceutical giant Eli Lilly, already reaping billions from its revolutionary weight-loss and diabetes treatments, may be on the verge of...

While Enphase Energy's leadership continues to express strong belief in the solar technology company's prospects, a notable divergence of opinion...

All eyes are on GameStop Corp. as it prepares to release its second-quarter fiscal 2025 results after market close on...

The global tobacco landscape is undergoing a significant transformation, and Philip Morris International (PMI) is at the forefront of this...

The quantum computing sector is witnessing an unprecedented consolidation play as IonQ, a leading developer in the field, leverages a...

Cardiff Oncology enters a crucial period with three major investor conferences scheduled for early September, providing the biotechnology firm with...